Practice·August 1, 2026 · 4 min read

21 CFR 820 didn't move. Its contents did.

FDA's Quality Management System Regulation, effective February 2, 2026, left the address unchanged and emptied most of what used to live there. A citation to Part 820 written last year and one written this year can point at the identical number and mean two different things.

By Connor Griggs — Regulatory & Quality Strategist

21 CFR 820.30 is a citation a device quality engineer has typed for decades without looking it up — design controls, the section a warning letter reached for whenever a firm shipped something its own design history couldn’t defend. As of February 2, 2026, that number is mostly a placeholder. The address didn’t move. What used to be filed under it did.

What the rule actually did

FDA’s final rule, published February 2, 2024, retitled Part 820 the Quality Management System Regulation and amended it to incorporate the international standard ISO 13485:2016 by reference — the harmonization the device industry had been asking for since long before this product existed. The rule carried a two-year runway: manufacturers had until February 2, 2026 to comply. That date is six months behind today, which means the version of Part 820 currently in force is not the one most people in this industry learned the numbering of.

What is actually left at the old addresses

The restructuring is not cosmetic. Subpart A now holds the scope, the definitions, the incorporation-by-reference itself, and one substantive operative section — 21 CFR 820.10, which requires a manufacturer to document a quality management system complying with the applicable requirements of ISO 13485 plus whatever else this part separately requires. Subpart B adds exactly two more sections: 820.35, control of records, and 820.45, device labelling and packaging controls. That is close to the entire regulation. The sections that used to carry their own detailed, standalone requirements — design controls at 820.30, corrective and preventive action at 820.100, complaint files at 820.198 — are reserved: the number still exists in the part, and there is no longer a rule written under it. The substance those numbers used to hold now lives in ISO 13485’s own clauses, reachable only by going through 820.10 first.

A citation to a CFR section is usually a citation to a fixed piece of text. For most of Part 820, as of this year, it is a citation to an empty room with a sign pointing somewhere else.

The same number, a different rule depending on when you ask

That makes a Part 820 citation carry something most regulation numbers don’t: a vintage. A warning letter issued in 2023 citing 820.30(g) was citing a specific, self-contained design-validation requirement, spelled out in the CFR text at that address. A finding issued after February 2026 cannot cite that same requirement the same way — it has to reach it through 820.10 and name the ISO 13485 clause the finding actually turns on. The regulation’s name for “design controls” didn’t disappear from the industry’s vocabulary. It disappeared from the one place a citation used to be able to stop and mean something on its own.

The practice

Anyone building a pattern out of historical Part 820 citations — the same exercise this blog has described for warning-letter subject lines, tallying a quarter’s worth of enforcement themes — now has to split that corpus at February 2, 2026 before trusting any trend across it. A count of “820.30” citations that drops to zero after that date is not evidence that design-control findings stopped. It is evidence that the citation moved to 820.10 with an ISO clause number doing the work 820.30 used to do alone. Reading the two eras as one continuous series, without accounting for the rewrite in between, would manufacture a trend that is really just a renumbering.

FDA Radar’s Federal Register filter lists “quality system regulation” and “qmsr” among the terms it checks before an item reaches the device-relevant feed at all, and every Federal Register item we ingest carries its cfr_references at the same part-level granularity as any other citation we handle — “21 CFR 820,” not the section beneath it. That catches a QMSR-related notice the same way it catches any other Part 820 document; what it changed underneath is still a person’s job to read. Whether a specific historical citation still means what it used to, for a specific finding you’re assessing, is a determination for whoever is reading that file — this is a description of what changed in the regulation’s own structure, never regulatory advice about a given citation’s current force.

Method
A Class I device, a Class I recall
Method
The product code that doesn't exist yet
Practice
The classification posts. The 483 behind it doesn't.
Method
A recall has three dates, and the pipeline had to pick one
Practice
The count is real. The rate is not.
Method
The firm on the record is not the firm on the box
Practice
Low confidence is an instruction, not a hedge
Method
The same company, spelled three ways
Practice
A device that was never a medical device
Method
FDA's warning letters, addressed by column number
Practice
Your regulation has a decimal. FDA's watch doesn't.
Method
Three letters is too short to search for
Practice
Most warning letters never close
Method
The guidance that skipped the draft
Practice
Ongoing, as of when?
Method
The least interesting fact in a 510(k)
Practice
No recall arrives with a product code attached
Practice
The deadline that doesn't email you
Method
The warning letter has two dates
Method
How to monitor FDA without drowning
Practice
Your predicate was recalled. Now what?
Method
Why no item reaches you without a human